Regulatory Affairs Professionals Society

Regulatory Affairs Professionals Society
Name	Regulatory Affairs Professionals Society
Abbreviation	RAPS
Formation	1976
Headquarters	Washington, D.C.
Type	Professional association
Region served	International
Membership	Professionals in medical product regulation

Regulatory Affairs Professionals Society

The Regulatory Affairs Professionals Society is an international professional association serving professionals involved in the regulation of medical products, including pharmaceuticals, biologics, medical devices, and combination products. It provides networking, education, certification, publications, and advocacy support to members working in industry, regulatory agencies, academia, and consulting. The organization convenes stakeholders across jurisdictions to address regulatory policy, compliance, and scientific developments affecting product lifecycle management.

History

Founded in 1976, the organization emerged as professionals handling regulatory submissions and compliance sought coordination amid evolving frameworks such as the Food and Drug Administration's expanding role and international harmonization efforts like the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. Early growth paralleled landmark developments including the Orphan Drug Act and legislative changes affecting European Medicines Agency procedures. Throughout the 1990s and 2000s the society expanded internationally in response to globalization exemplified by the World Health Organization's initiatives and multilateral trade arrangements like the North American Free Trade Agreement. Strategic partnerships and conferences reflected connections with institutions such as the U.S. Pharmacopeia, Health Canada, and regional regulatory bodies in Asia and Latin America.

Mission and Activities

The society’s mission emphasizes professional development, best practices, and advancing public health by improving regulatory science and policy. Activities include stakeholder engagement with agencies such as the Food and Drug Administration, collaboration with standards organizations like the International Organization for Standardization, and participation in policy dialogues influenced by documents from the European Commission and the World Trade Organization. It organizes conferences and working groups that intersect with topics addressed by entities like the Centers for Disease Control and Prevention, the National Institutes of Health, and academic centers including the Johns Hopkins University and Massachusetts Institute of Technology.

Membership and Certification

Membership attracts professionals from multinational companies such as Pfizer, Roche, Johnson & Johnson, Novartis, and contract research organizations including Quintiles/IQVIA. Individual members often include former officials from regulatory agencies like the U.S. Food and Drug Administration and European Medicines Agency as well as consultants from firms such as McKinsey & Company and Deloitte. The society administers certification programs that align with competency frameworks similar to professional credentials offered by bodies like the Project Management Institute and the American Society for Quality. Recognition and awards connect members to broader professional networks including associations like the American Pharmacists Association and the Drug Information Association.

Education and Training

Educational offerings encompass webinars, workshops, and conferences that feature speakers from institutions such as the Food and Drug Administration, Health Canada, European Medicines Agency, and industry leaders from GlaxoSmithKline and AstraZeneca. Training topics span regulatory strategy, clinical trial regulation involving concepts linked to the Declaration of Helsinki, medical device regulation paralleling standards from the International Electrotechnical Commission, and pharmacovigilance practices connected to surveillance programs at the World Health Organization. Partnerships with universities such as University of California, San Francisco and professional schools provide continuing education and executive programs.

Publications and Communications

The society publishes newsletters, guidance documents, and technical reports that draw on regulatory science discussions similar to white papers produced by the National Academies of Sciences, Engineering, and Medicine and policy analyses akin to those from the Brookings Institution. Its communications channels include journals, member magazines, and online platforms used to disseminate updates about regulatory actions from the Food and Drug Administration, decisions from the European Medicines Agency, and international guidance from the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.

Governance and Organization

Governance is led by a board of directors and volunteer committees, modeled on structures used by professional organizations such as the American Medical Association, Institute of Electrical and Electronics Engineers, and the American Bar Association. Operational leadership coordinates chapters and regional groups across continents, engaging with national regulatory authorities including the Medicines and Healthcare products Regulatory Agency in the United Kingdom, Pharmaceuticals and Medical Devices Agency in Japan, and agencies in Australia and Brazil. Strategic alliances and advisory committees link the society to stakeholder organizations like the Biotechnology Innovation Organization and patient advocacy groups that collaborate on regulatory policy.

Category:Professional associations Category:Health care industry organizations